Top Markets
Coin of the day
Novonesis (Novozymes) B Novonesis (Novozymes) B

Novonesis (Novozymes) B

NSISBC
Rangering i aksjer #1197
Established in January 2024 through the amalgamation of Novozymes A/S and Chr.... Established in January 2024 through the amalgamation of Novozymes A/S and Chr. Hansen, Novonesis now stands as a prominent global leader in biosolutions. The firm's activities encompass the worldwide development and commercialization of industrial enzymes, diverse microorganisms, and vital biopharmaceutical ingredients. Distinctively, its Class B shares are listed independently and actively traded on various European exchanges.
Aksjekurs
$72.44
Sist synkronisert: 2026-08-24
Markedsverdi
$20.13B
Endring (1 dag)
1.25%
Endring (1 år)
17.60%
Land
DK
Handel Novonesis (Novozymes) B (NSISBC)
Utbytteavkastning for Novonesis (Novozymes) B (NSISBC)
Novonesis (Novozymes) B (aksjesymbol: NSISBC) sin utbytteavkastning (TTM) per 2026 er: 0
Gjennomsnittlig utbytteavkastning de siste 5 årene: 0.00%
Utbytteavkastning for Novonesis (Novozymes) B (NSISBC) fra 2026 til 2026
Utbytteavkastning ved slutten av hvert år (TTM)
År Utbytteavkastning Endre
Ikke nok data for de angitte datoene.
Utbytteavkastning (TTM) for lignende selskaper eller konkurrenter